The policy would help the state move to a higher-level of life sciences products and R&D in areas including biologicals, neutraceuticals and bio-medical devices.
Andhra Pradesh is among the top in the country in bulk drugs production, he said. Announcing BioAsia 2014 to be held here from February 17-19, he said globally in 2-3 years, around $15 billion worth biological drugs would be placed in the non-patent segment. "India is well-placed here with its world-class pharma manufacturing facilities, R&D, and international presence," Chandra said. BioAsia 2014 is being held in partnership with the UK government. The theme at the technology and bio-business platform is 'Fostering Innovations in Life Sciences R&D'.